NCT04517760

Brief Summary

The goal of the research was to evaluate the performance of items within the Kizazi Kipya (K2) Orphan and Vulnerable Children (OVC) HIV risk screening tool in identifying HIV-positive children, to optimize an HIV screening tool for OVC and children and adolescents in facility settings and to assess the feasibility and acceptability of home-based HIV risk screening and testing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21,080

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 18, 2020

Completed
Last Updated

August 18, 2020

Status Verified

August 1, 2020

Enrollment Period

1.6 years

First QC Date

August 12, 2020

Last Update Submit

August 17, 2020

Conditions

Keywords

HIV Screen toolorphans and vulnerable childrenTanzania

Outcome Measures

Primary Outcomes (6)

  • Sensitivity of HIV risk screening tool

    Children/adolescents testing HIV positive on the tool who are truly HIV positive

    Within four weeks

  • Specificity of HIV risk screening tool

    Children/adolescents testing HIV negative on the tool who are truly HIV negative

    Within four weeks

  • Positive predictive value

    Proportion of children/adolescents testing positive on the tool who actually have HIV

    Within four weeks

  • Negative predictive value

    Proportion of children/adolescents testing negative on the tool who do not actually have HIV

    Within four weeks

  • Acceptability of HIV risk screening tool

    Examining the extent of reception of the screening tool by the OVC caregivers and the community case workers using a semi-structured questionnaire

    Within six weeks

  • Feasibility of HIV risk screening tool

    Exploring the practicality of use of HIV risk screening tool through focus group discussions with community case workers

    Within six weeks

Eligibility Criteria

Age2 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and adolescents (and their caregivers as applicable) participating in an orphans and vulnerable children (OVC) program or presenting for services at a study facility. Community care workers (CCWs) who have been conducting HIV risk screening in OVC households as part of their role in the OVC program.

You may qualify if:

  • Living in a household deemed to be at elevated HIV risk based on previously identified risk criteria
  • Attending a study health facility in two regions of Tanzania
  • Age 2-19 years

You may not qualify if:

  • Previously tested HIV-positive
  • History of antiretroviral treatment (ART)
  • Unable or unwilling to be consented
  • Age 5-19 years old, tested negative in past 6 months, and having no reported exposure to HIV through sexual contact (consensual, abuse) or through blood transfusion/needle injury.
  • Community care workers:
  • conducting HIV risk screening in OVC households as part of their role in the Kizazi Kipya project in the subset of study districts where structured observations and focus group discussions were conducted
  • unwilling to consent to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elizabeth Glaser Pediatric AIDS Foundation

Dar es Salaam, Tanzania

Location

Study Officials

  • Gretchen Antelman, PhD

    E. Glaser Pediatric AIDS Found

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 18, 2020

Study Start

February 22, 2018

Primary Completion

September 30, 2019

Study Completion

September 30, 2019

Last Updated

August 18, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will share

The IPD sharing plan will include the final quantitative datasets, tools, data dictionaries and analytic code will be made publicly available through a Dataverse repository.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
End 2020
Access Criteria
Dataverse repository

Locations